How effective is Klor-con M20 for Hypokalemia? (a real world drug study)

Summary:

Overall ratings: 3.5/5
Long term ratings: 3.7/5

This is a phase IV clinical study of how effective Klor-con m20 (potassium chloride) is for Hypokalemia and for what kind of people. The study is created by eHealthMe from 61 Klor-con m20 users and is updated continuously.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.

What is Hypokalemia?

Hypokalemia (low potassium) is found to be associated with 2,089 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Hypokalemia.


On Aug, 08, 2026

61 people are studied for taking Klor-con m20 in Hypokalemia

Overall effectiveness (number of people):

Does Klor-con m20 work for your Hypokalemia (overall)?

Long term (1+ years) effectiveness (number of people):

Does Klor-con m20 work for your Hypokalemia (long term)?

Klor-con m20 effectiveness for Hypokalemia (number of people):

Overall:
  • not at all: 0
  • somewhat: 9
  • moderate: 23
  • high: 21
  • very high: 8
Long Term:
  • not at all: 0
  • somewhat: 5
  • moderate: 10
  • high: 19
  • very high: 7

Gender of people who take Klor-con m20 for Hypokalemia *:

  • female: 68.85 %
  • male: 31.15 %

Age of people who take Klor-con m20 for Hypokalemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.2800000000000002 %
  • 30-39: 6.5600000000000005 %
  • 40-49: 16.39 %
  • 50-59: 22.95 %
  • 60+: 50.82 %

Who find Klor-con M20 more effective for Hypokalemia?

Gender of people who take Klor-con m20 for Hypokalemia *:

  • female: 65.52 %
  • male: 34.48 %

Age of people who take Klor-con m20 for Hypokalemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.45 %
  • 30-39: 6.9 %
  • 40-49: 17.24 %
  • 50-59: 24.14 %
  • 60+: 48.28 %

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con m20?

- You can start a phase IV clinical trial to monitor Klor-con m20 safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on potassium chloride (the active ingredients of Klor-con m20) and Klor-con m20 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: